Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9056140 Pharmaceutical compound

Patent 9056140 was granted and assigned to Biocopea Limited on June, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 13 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12006314 Anti-cancer nuclear hormone receptor-targeting compounds
0
Edits on 10 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11952349 Anti-cancer nuclear hormone receptor-targeting compounds
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11834458 Anti-cancer nuclear hormone receptor-targeting compounds
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+242 characters)
Article

Patent abstract

Provided is a compound comprising:(a) a first component capable of binding to ER+ cell receptors; and(b) a second component;wherein the second component is a ribosome inactivating toxin and is conjugated to the first component.

Edits on 28 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 28 Sep, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Gregory Alan Stoloff0
Wilson Romero Caparros-Wanderley0
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090561400
Edits on 21 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09056140 Pharmaceutical compound US Patent 9056140 Pharmaceutical compound

Infobox
Patent Number
090561400
Patent Number
90561400
Edits on 26 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
‌
Biocopea Limited
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
090561400
Date of Patent
June 16, 2015
0
Patent Application Number
126777010
Date Filed
September 11, 2008
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=090561400
Patent Primary Examiner
‌
Susan Tran
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09056140
Edits on 2 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 2 Jan, 2022
Edits made to:
Infobox (+8 properties)
‌

 US Patent 09056140 Pharmaceutical compound

Infobox
Is a
Patent
Patent
Current assignee
‌
Biocopea Limited
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09056140
Date of patent
June 16, 2015
Patent application number
12677701
Date Filed
September 11, 2008
Patent primary examiner
‌
Susan Tran

Find more entities like US Patent 9056140 Pharmaceutical compound

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo